Benidipine

Benidipine is a dihydropyridine calcium channel blocker distinguished by its triple blocking action across L-, N- and T-type calcium channels, used for hypertension predominantly in Japanese and other Asian markets. Simson Pharma's Benidipine reference standard and impurities support stability-indicating method development for this multi-channel antihypertensive.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Benidipine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Benidipine
Benidipine Hydrochloride
Benidipine Impurity 1
Dehydro Benidipine
(S,S)-Benidipine Hydrochloride
(3S,4`R)-Benidipine Hydrochloride
(3R,4`S)-Benidipine Hydrochloride
(R,R)-Benidipine Hydrochloride
Des-Benzyl Benidipine
Benidipine Impurity 4
Benidipine Impurity 5
(R,S)(S,R)-Benidipine Hydrochloride
Benidipine Nitroso Impurity 1
Benidipine Diastereomer Impurity

Isotope Labelled Compounds

(-)-alfa-Benidipine-d5 Hydrochloride
(+)-alpha-Benidipine-D5
RAC Benidipine D7